# Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer

> **NCT00137436** · PHASE1,PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 93 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Prednisone
- **DRUG:** SU011248

## Key facts

- **NCT ID:** NCT00137436
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-05
- **Final completion:** 2010-03
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2011-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137436, "Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00137436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*